Research & Insights

Data-driven business cases, industry analysis, and technical insights from the Meldra engineering and research teams.

The Billion-Dollar Blind Spot: Why Global Pharma Needs Immutable ESG Data

A factual business case exploring why pharmaceutical leaders must adopt immutable data architectures to comply with strict SBTi and CSRD requirements, avoiding devastating market revocations.

Read Full Article

Automating Global Customs Clearance with NLP

Coming Soon: How intelligent document processing reduces international logistics delays by structuring complex, multilingual customs declarations.

Publishing Next Week